Question

Difficulty: MediumHematology and Oncology

A 4545-year-old man with recently diagnosed Burkitt lymphoma is evaluated in the hospital on the second day of his induction chemotherapy regimen. He reports new-onset nausea, generalized weakness, and severe muscle cramps. Over the past 1212 hours, his urine output has decreased to approximately 200200 mL. His temperature is 37.2∘C37.2^\circ\text{C} (99.0∘F99.0^\circ\text{F}), blood pressure is 118/76118/76 mmHg, pulse is 114114/min, and respirations are 1818/min. Physical examination reveals muscle fasciculations and diffuse weakness. Laboratory studies show the following:

Laboratory TestResult
Sodium138138 mEq/L
Potassium7.17.1 mEq/L
Chloride102102 mEq/L
Bicarbonate1818 mEq/L
Blood urea nitrogen4545 mg/dL
Creatinine3.23.2 mg/dL
Calcium6.56.5 mg/dL
Phosphorus7.27.2 mg/dL
Uric acid14.114.1 mg/dL

An electrocardiogram is obtained and demonstrates peaked T waves, flattened P waves, and a widened QRS complex. Which of the following is the most appropriate initial step in the management of this patient?

  1. Administration of intravenous calcium gluconateAnswer
  2. B
    Administration of intravenous regular insulin and dextrose
  3. C
    Administration of intravenous rasburicase
  4. D
    Initiation of urgent hemodialysis
  5. E
    Continuous intravenous infusion of normal saline

Answer

The most appropriate initial step is the administration of intravenous calcium gluconate to stabilize the cardiac membrane.
The correct answer is the administration of intravenous calcium gluconate. This patient is experiencing tumor lysis syndrome (TLS), an oncologic emergency caused by the massive release of intracellular contents following the initiation of cytotoxic chemotherapy, particularly in high-grade tumors like Burkitt lymphoma. TLS is characterized by hyperkalemia, hyperphosphatemia, hyperuricemia, and hypocalcemia, which can lead to acute kidney injury and fatal arrhythmias. The most immediate threat to this patient's life is severe hyperkalemia (7.17.1 mEq/L) with progressive electrocardiographic (ECG) changes (peaked T waves, flattened P waves, and a widened QRS complex), which can rapidly degenerate into ventricular fibrillation or asystole. The most appropriate initial step in any patient with hyperkalemia and significant ECG changes is to administer intravenous calcium (gluconate or chloride). Calcium does not lower serum potassium levels; rather, it directly antagonizes the membrane actions of hyperkalemia, thereby raising the threshold potential and stabilizing the cardiac myocardium. This effect is almost immediate, buying time to administer definitive potassium-lowering therapies.

Step-by-Step Solution

1
Identify the primary diagnosis and its complications.
The patient has tumor lysis syndrome (TLS), evidenced by hyperuricemia, hyperkalemia, hyperphosphatemia, and hypocalcemia following chemotherapy for a high-grade lymphoma.
Recognizing TLS is crucial for anticipating specific electrolyte emergencies.
2
Identify the most immediate life-threatening abnormality.
The patient has severe hyperkalemia (7.17.1 mEq/L) with corresponding electrocardiogram changes (peaked T waves, widened QRS).
ECG changes indicate impending fatal arrhythmias (e.g., ventricular fibrillation), which take precedence over all other laboratory abnormalities.
3
Determine the first-line intervention for this specific emergency.
Intravenous calcium (gluconate or chloride) must be administered immediately.
Calcium directly antagonizes the membrane effects of potassium, stabilizing the cardiac action potential while other measures (like insulin and dextrose) are prepared to lower serum potassium levels.

Key Concept

In patients with tumor lysis syndrome, severe hyperkalemia with electrocardiographic changes is a medical emergency that requires immediate cardiac membrane stabilization with intravenous calcium before administering therapies to lower serum potassium.
Estimated Time:1m 30s
Rate this question